Sentences with phrase «thai vaccine trial»

In January 2004, a group of respected investigators wrote to Science voicing their concern about the wisdom of the US government in sponsoring the Thai vaccine trial.

In 2009, the RV144 Thai vaccine trial provided the first evidence in humans that a safe and effective preventive HIV vaccine is possible.

Not exact matches

Costing $ 105 million and enrolling more than 16,000 subjects, the Thai clinical trial was the largest AIDS vaccine test to date.

The long - awaited trials have the backing of the Thai government and the WHO, and the vaccine's safety has been thoroughly tested in the US.

The row over the Thai trials has been fuelled by an explosive mix of factors, including the pace at which the HIV epidemic is growing in Asia, the future of the vaccines industry, and domestic tensions in the US between AIDS researchers, activists and politicians.

The event included a scientific lecture on Thai HIV vaccine trial (RV 144) and presentations on milestones achieved over the decade (2002 — 2012) in the different programs.

The panel discussed progress that's been made including the follow - up to the RV144 Thai prime - boost trial results and in the development of the next generation of vaccine candidates for testing.

Many scientists believe that the Thai HIV vaccine trial, which had recruited over 2,500 of its projected 16,000 participants by June 2004, has no chance of success.4 Yet the investigators overseeing the study (who include American scientists), the local Thai institutional review boards, and the Thai Ministry of Health have all remained silent — at least on the record.

At the AIDS Vaccine conference in Bangkok on Tuesday, scientists announced an update to a Thai trial of a «modestly effective» experimental AIDS vVaccine conference in Bangkok on Tuesday, scientists announced an update to a Thai trial of a «modestly effective» experimental AIDS vaccinevaccine.

It played a critical role landmark RV144 «Thai Study,» a 16,000 person study which was the only HIV vaccine trial to date to demonstrate modest (31 %) efficacy of a potential HIV vaccine, and the follow - on studies on the RV144 correlates of risk.

Immunogenicity of ALVAC - HIV (vCP1521) and AIDSVAX B / E Prime Boost Vaccination in RV144, Thai Phase III HIV Vaccine Trial

Glenda Gray, executive director of the Wits Health Consortium's perinatal HIV research unit in South Africa, presented data today at the HIV R4P conference in Cape Town indicating that the prime - boost vaccine candidates initially tested in the RV144 trial in Thailand — the only HIV vaccine trial to date to show any efficacy — induced cross-clade immune responses in a Phase I safety trial conducted in South Africa, with immunogenicity similar to or greater than that of the responses induced in Thai volunteers.